Auditory Evoked Potentials in Borderline Personality Disorder

Andrulonis PA Glueck BC Stroebel CF Organic brain dysfunction and the borderline syndrome. Psychiat Clin North Am 1980; 4:47–66.

Cowdry RW Gardner D.L. Pharmacotherapy of borderline personality disorder: Alprazolam, carbamazepine, trifluroperazine, and tranylcypromine. Arch Gen Psychiat 1988; 45:111–119.

Baxter L Edell W Gerner R Dexamethasone suppression test and axis I diagnosis of inpatients with DSM-III borderline personality disorder. J Clin Psychiat 1984; 45:150–153.

Garbutt JC Loosen PT Tipermas A. The TRH test in patients with borderline personality disorder. Psychiat Res 1983; 9:107–113.

Reynolds CF Soloff PH Kupfer DJ Depression in borderline patients: A prospective EEG sleep study. Psychiat Res 1985; 14:1–15.

Snyder S Pitts WM Gusten Q. CT scans of patients with borderline personality disorder. Am J Psychiat 1983; 140:272–274.

Fenwick P. EEG studies. In: Reynolds EH Trimble MR (eds). Epilepsy and Psychiatry. New York: Churchill Livingstone; 1981.

Snyder S Pitts W.M. Electroencephalography of DSM-III borderline personality disorder. Acta Psychiatr Scand 1984; 69:129–134.

Cornelius JR Brenner RP Soloff PH EEG abnormalities in borderline personality disorder: Specific or nonspecific. Biol Psychiat 1986; 21:977–980.

Archer RP Struve FA Ball JD Gordon R.A. EEG in borderline personality disorder. Biol Psychiat 1988; 24:731–732.

Cornelius RJ Schulz C Brenner RP Changes in EEG mean frequency associated with anxiety and with amphetamine challenge in BPD. Biol Psychiat 1988; 24:587–594.

Loiselle D Stamm J Maitinsky S Whipple S. Evoked potential in behavioral signs of attentive dysfunction in hyperactive boys. Psychophysiol 1980; 17:2.

Josef NC Lycaki H Chayasirisobhon S. Brainstem auditory evoked potential in antisocial personality. Clin Electroencephalogr 1985; 16:91–93.

Cannon PA Drake ME Jr. EEG and brainstem auditory evoked potentials in brain injured patients with rage attacks and self injurious behavior. Clin Electroencephalogr 1986; 17:169–172.

Blackwood DHR St. Clair DM Kutchen S.P. P300 event-related potential abnormalities in BPD. Biol Psychiat 1986; 21:557–560.

Kutcher SP Blackwood DHR St. Clair DM Auditory P300 in Borderline PD and schizophrenia. Arch Gen Psychiat 1987; 44:645–650.

Kutcher SP Blackwood DHR Gaskell BF Auditory P300 does not differentiate borderline personality disorder from schizotypal personality disorder. Biol Psychiat 1989; 26:766–744.

Chapin K Wightman L Lycaki H Difference in reaction time between subjects with schizotypal and borderline personality disorders. Amer J Psychiat 1987; 144:948–950.

American Psychiatric Association, Task Force on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders. Third ed, revised. Washington, DC. American Psychiatric Association; 1987.

Celesia GC Grigg M.H. Auditory evoked potentials. In: Niedermeyer E da Silva F. Lopes (eds). Electroencephalography. Baltimore: Urban and Schwarzenberg; 1987:797–817.

Begleiter H Porjesz B.P. The P300 component of the event-related brain potential in psychiatric patients. In: Cracco RQ Bodis-Wollner I (eds). Evoked Potentials. New York: Alan R. Liss; 1986:529–535.

Halgren E Squires NK Wilson CL Endogenous potentials generated in the human hippocampal formation and amygdala by infrequent events. Science 1980; 210:803–805.

Okada YC Kaufman L Williamson S.J. The hippocampal formation as a source of the slow endogenous potentials. Electroencephalogr Clin Neurophysiol 1983; 55:417–426.

Duncan-Johnson C Donchin E. The time constant in P300 recording. Psychophysiol 1979; 16:53–55.

Ruchkin DS Sutton S. Positive slow wave and P300-association and dissociation. In: Gaillard AWK Rutter W (eds). Tutorials in ERP Research: Endogenous Components. Groningen: North Holland; 1983.

Ebmeier KP Potter DD Cochrane RHB Lower-bandpass filter frequency in P3 experiments: A possible cause for divergent results in schizophrenia research. Biol Psychiat 1990; 27:667–670.

Kline DF Greenburg I.M. Behavioral effects of diphenylhydantoin in severe psychiatric disorders. Am J Psychiat 1967; 124:847.

Gardner DL Cowdry R.W. Positive effects of carbamazepine on behavior dyscontrol in borderline personality disorder. Am J Psychiat 1986; 143:519–522.

Andrulonis PA Glueck BC Stroebel CF Vogel N.G. Borderline personality subcategories. J Nerv Ment Dis 1982; 170:670–677.

Kellner CH Post RM Putnam F Intravenous procaine as a probe of limbic system activity in psychiatric patients and normal controls. Biol Psychiatry 1987; 22:1107–1126.